↓ Skip to main content

Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients

Overview of attention for article published in Multiple Sclerosis and Related Disorders, April 2021
Altmetric Badge

Mentioned by

twitter
1 tweeter

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients
Published in
Multiple Sclerosis and Related Disorders, April 2021
DOI 10.1016/j.msard.2021.102754
Pubmed ID
Authors

Giulia Mallucci, Antonio Zito, Fausto Baldanti, Matteo Gastaldi, Beatrice Dal Fabbro, Diego Franciotta, Roberto Bergamaschi

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 40%
Librarian 1 20%
Other 1 20%
Student > Bachelor 1 20%
Readers by discipline Count As %
Unspecified 1 20%
Nursing and Health Professions 1 20%
Social Sciences 1 20%
Neuroscience 1 20%
Medicine and Dentistry 1 20%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2021.
All research outputs
#15,115,840
of 17,100,199 outputs
Outputs from Multiple Sclerosis and Related Disorders
#1,370
of 1,705 outputs
Outputs of similar age
#128,544
of 156,844 outputs
Outputs of similar age from Multiple Sclerosis and Related Disorders
#64
of 92 outputs
Altmetric has tracked 17,100,199 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,705 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,844 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.